Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63.

Article  PubMed  Google Scholar 

Stahl JM, Corso CD, Verma V, Park HS, Nath SK, Husain ZA, Simone CB 2nd, Kim AW, Decker RH. Trends in stereotactic body radiation therapy for stage I small cell lung cancer. Lung Cancer. 2017;103:11–6.

Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010;303(11):1070–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, Ewing M, Abdulrahman R, DesRosiers C, Williams M, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24(30):4833–9.

Article  PubMed  Google Scholar 

Bezjak A, Paulus R, Gaspar LE, Timmerman RD, Straube WL, Ryan WF, Garces YI, Pu AT, Singh AK, Videtic GM, et al. Safety and efficacy of a Five-Fraction stereotactic body radiotherapy schedule for centrally located Non-Small-Cell lung cancer: NRG oncology/rtog 0813 trial. J Clin Oncol. 2019;37(15):1316–25.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chang JY, Li QQ, Xu QY, Allen PK, Rebueno N, Gomez DR, Balter P, Komaki R, Mehran R, Swisher SG, et al. Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a no fly zone. Int J Radiat Oncol Biol Phys. 2014;88(5):1120–8.

Article  PubMed  Google Scholar 

Haasbeek CJ, Lagerwaard FJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer. J Thorac Oncol. 2011;6(12):2036–43.

Article  PubMed  Google Scholar 

Chaudhuri AA, Tang C, Binkley MS, Jin M, Wynne JF, von Eyben R, Hara WY, Trakul N, Loo BW Jr., Diehn M. Stereotactic ablative radiotherapy (SABR) for treatment of central and ultra-central lung tumors. Lung Cancer. 2015;89(1):50–6.

Article  PubMed  Google Scholar 

Rim CH, Kim Y, Kim CY, Yoon WS, Yang DS. Is stereotactic body radiotherapy for ultra-central lung tumor a feasible option? A systemic review and meta-analysis. Int J Radiat Biol. 2019;95(3):329–37.

Article  CAS  PubMed  Google Scholar 

Tekatli H, Haasbeek N, Dahele M, De Haan P, Verbakel W, Bongers E, Hashemi S, Nossent E, Spoelstra F, de Langen AJ, et al. Outcomes of hypofractionated High-Dose radiotherapy in Poor-Risk patients with ultracentral Non-Small cell lung Cancer. J Thorac Oncol. 2016;11(7):1081–9.

Article  PubMed  Google Scholar 

Raman S, Yau V, Pineda S, Le LW, Lau A, Bezjak A, Cho BCJ, Sun A, Hope AJ, Giuliani M. Ultracentral tumors treated with stereotactic body radiotherapy: Single-Institution experience. Clin Lung Cancer. 2018;19(5):e803–10.

Article  PubMed  Google Scholar 

Schefter SSLBSTJJLTE. Stereotactic Body Radiation Therapy.

Xhaferllari I, El-Sherif O, Gaede S. Comprehensive dosimetric planning comparison for early-stage, non-small cell lung cancer with SABR: fixed-beam IMRT versus VMAT versus tomotherapy. J Appl Clin Med Phys. 2016;17(5):329–40.

Article  PubMed  PubMed Central  Google Scholar 

Haseltine JM, Rimner A, Gelblum DY, Modh A, Rosenzweig KE, Jackson A, Yorke ED, Wu AJ. Fatal complications after stereotactic body radiation therapy for central lung tumors abutting the proximal bronchial tree. Pract Radiat Oncol. 2016;6(2):e27–33.

Article  PubMed  Google Scholar 

Wang C, Rimner A, Gelblum DY, Dick-Godfrey R, McKnight D, Torres D, Flynn J, Zhang Z, Sidiqi B, Jackson A, et al. Analysis of pneumonitis and esophageal injury after stereotactic body radiation therapy for ultra-central lung tumors. Lung Cancer. 2020;147:45–8.

Article  PubMed  Google Scholar 

Stam B, Peulen H, Guckenberger M, Mantel F, Hope A, Werner-Wasik M, Belderbos J, Grills I, O’Connell N, Sonke JJ. Dose to heart substructures is associated with non-cancer death after SBRT in stage I-II NSCLC patients. Radiother Oncol. 2017;123(3):370–5.

Article  PubMed  Google Scholar 

Han CB, Wang WL, Quint L, Xue JX, Matuszak M, Ten Haken R, Kong FM. Pulmonary artery invasion, high-dose radiation, and overall survival in patients with non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 2014;89(2):313–21.

Article  PubMed  PubMed Central  Google Scholar 

Loi M, Franceschini D, Dominici L, Chiola I, Franzese C, D’Agostino GR, Navarria P, Marzo M, Paganini L, Comito T, et al. Dose coverage impacts local control in ultra-central lung oligometastases treated with stereotactic radiotherapy. Strahlenther Onkol. 2021;197(5):396–404.

Article  PubMed  Google Scholar 

Wang Q, Qin J, Cao R, Xu T, Yan J, Zhu S, Wu J, Xu G, Zhu L, Jiang W, et al. Comparison of dosimetric benefits of three precise radiotherapy techniques in nasopharyngeal carcinoma patients using a Priority-Classified plan optimization model. Front Oncol. 2021;11:646584.

Article  PubMed  PubMed Central  Google Scholar 

Rong Y, Welsh JS. Dosimetric and clinical review of helical tomotherapy. Expert Rev Anticancer Ther. 2011;11(2):309–20.

Article  PubMed  Google Scholar 

Meng LL, Feng LC, Wang YL, Dai XK, Xie CB. Dosimetric comparison between helical tomotherapy and intensity-modulated radiation therapy plans for non-small cell lung cancer. Chin Med J (Engl). 2011;124(11):1667–71.

PubMed  Google Scholar 

Rong Y, Tang G, Welsh JS, Mohiuddin MM, Paliwal B, Yu CX. Helical tomotherapy versus single-arc intensity-modulated Arc therapy: a collaborative dosimetric comparison between two institutions. Int J Radiat Oncol Biol Phys. 2011;81(1):284–96.

Article  PubMed  Google Scholar 

Holmes TW, Hudes R, Dziuba S, Kazi A, Hall M, Dawson D. Stereotactic image-guided intensity modulated radiotherapy using the HI-ART II helical tomotherapy system. Med Dosim. 2008;33(2):135–48.

Article  PubMed  Google Scholar 

Hodge W, Tome WA, Jaradat HA, Orton NP, Khuntia D, Traynor A, Weigel T, Mehta MP. Feasibility report of image guided stereotactic body radiotherapy (IG-SBRT) with tomotherapy for early stage medically inoperable lung cancer using extreme hypofractionation. Acta Oncol. 2006;45(7):890–6.

Article  PubMed  Google Scholar 

Rosen LR, Fischer-Valuck BW, Katz SR, Durci M, Wu HT, Syh J, Syh J, Patel B. Helical image-guided stereotactic body radiotherapy (SBRT) for the treatment of early-stage lung cancer: a single-institution experience at the Willis-Knighton Cancer center. Tumori. 2014;100(1):42–8.

Article  PubMed  Google Scholar 

Chi A, Jang SY, Welsh JS, Nguyen NP, Ong E, Gobar L, Komaki R. Feasibility of helical tomotherapy in stereotactic body radiation therapy for centrally located early stage non–small-cell lung cancer or lung metastases. Int J Radiat Oncol Biol Phys. 2011;81(3):856–62.

Article  PubMed  Google Scholar 

Nagai A, Shibamoto Y, Yoshida M, Inoda K, Kikuchi Y. Safety and efficacy of intensity-modulated stereotactic body radiotherapy using helical tomotherapy for lung cancer and lung metastasis. Biomed Res Int. 2014;2014:473173.

Article  PubMed  PubMed Central  Google Scholar 

Amin NP, Nalichowski A, Campbell S, Hyder J, Spink R, Konski AA, Dominello M. Helical therapy is safe for lung stereotactic body radiation therapy despite limitations in achieving Sharp dose gradients. Technol Cancer Res Treat. 2017;16(6):1173–8.

Article  PubMed  PubMed Central  Google Scholar 

Fan S, Zhang Q, Chen J, Chen G, Zhu J, Li T, Xiao H, Du S, Zeng Z, He J. Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via helical tomotherapy for early-stage lung cancer with or without pathological proof. Radiat Oncol. 2023;18(1):49.

Article  PubMed  PubMed Central  Google Scholar 

Aibe N, Yamazaki H, Nakamura S, Tsubokura T, Kobayashi K, Kodani N, Nishimura T, Okabe H, Yamada K. Outcome and toxicity of stereotactic body radiotherapy with helical tomotherapy for inoperable lung tumor: analysis of grade 5 radiation pneumonitis. J Radiat Res. 2014;55(3):575–82.

Article  PubMed  PubMed Central  Google Scholar 

Tomita N, Kodaira T, Matsuo M, Furutani K, Tachibana H, Daimon T, Shimizu H. Helical tomotherapy for solitary lung tumor: feasibility study and dosimetric evaluation of treatment plans. Technol Cancer Res Treat. 2010;9(4):407–15.

Article  PubMed  Google Scholar 

Baisden JM, Romney DA, Reish AG, Cai J, Sheng K, Jones DR, Benedict SH, Read PW, Larner JM. Dose as a function of lung volume and planned treatment volume in helical tomotherapy intensity-modulated radiation therapy-based stereotactic body radiation therapy for small lung tumors. Int J Radiat Oncol Biol Phys. 2007;68(4):1229–37.

Article  PubMed  Google Scholar 

He J, Huang Y, Shi S, Hu Y, Zeng Z. Comparison of effects between central and peripheral stage I lung Cancer using Image-Guided stereotactic body radiotherapy via helical tomotherapy. Technol Cancer Res Treat. 2015;14(6):701–7.